Wikidata

(Q63578627)

English

A Dose Ranging Placebo-Controlled Double-Blind Study to Evaluate the Safety and Efficacy of Tezepelumab in Atopic Dermatitis

clinical trial

In more languages

Statements

title
A Dose-Ranging, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Tezepelumab Alone or Combined With Topical Corticosteroids in Moderate-to-Severe Atopic Dermatitis (English)
0 references
medical condition
dermatitis
0 references
eczema
0 references
sponsor
Amgen
0 references
country
Australia
0 references
Canada
0 references
Japan
0 references
United Kingdom
0 references
main subject
dermatitis
0 references
dermatology
0 references
start time
15 March 2019
0 references
end time
1 March 2020
0 references
number of participants
300
0 references
minimum age
18 year
0 references
maximum age
75 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q63578627&oldid=1857278546"